Cipla is among the stocks to watch today following developments related to its US regulatory operations. The pharmaceutical company remains closely tracked by investors because the US market is a significant contributor to its international business.
Investors will be watching regulatory developments, product approvals and the company’s US launch pipeline for their potential impact on future revenue.
The broader pharmaceutical sector could also remain defensive if geopolitical uncertainty continues to weigh on cyclical sectors.
